Cancer Screening for Women / Immunization For Cervical cancer
Cancer Screening for Women/Immunisation For Cervical cancer
Cervical cancer screening is performed to detect abnormal changes in the cells of the cervix before they become cancerous or to detect cervical cancer at an early stage.
The primary screening method is the Pap test (Pap smear), which involves collecting a sample of cells from the cervix to examine for any abnormalities.
Another screening test is the HPV (human papillomavirus) test, which checks for the presence of high-risk HPV types that can cause cervical cancer.
It is recommended that women start regular cervical cancer screening at age 21 or within three years of becoming sexually active, whichever comes first.
The frequency of screening may vary based on the woman's age and the type of screening test used.
Early detection through screening allows for timely intervention and treatment, which can significantly increase the chances of successful outcomes.
Human papillomavirus (HPV) vaccination is a preventive measure to protect against certain types of HPV infections that can cause cervical and other types of cancers.
The HPV vaccine is typically administered in two or three doses over a six-month period.
Vaccination is most effective when given before a person becomes sexually active and is recommended for both males and females, typically between the ages of 9 and 26.
The HPV vaccine is safe and highly effective in preventing infections with the HPV types covered by the vaccine.
By preventing HPV infections, the vaccine significantly reduces the risk of developing cervical cancer and other HPV-related cancers.
In addition to cervical cancer screening, there are other important cancer screenings for women, including breast cancer screening (mammograms), Ovarian cancer screening and uterine cancer screening.
The recommended age and frequency of these screenings may vary depending on individual factors such as family history, age and overall health.
Regular cancer screenings can help detect abnormalities or cancerous changes early, allowing for prompt treatment and better outcomes.
It’s important for women to discuss their individual risk factors and screening recommendations with their healthcare provider. Regular screenings and immunizations can significantly contribute to the prevention, early detection and successful management of cancer in women.
